




Curry Berentstein ☀️
2.3K posts

@berentstein
Blockchain, Podcasting, Reading, Exercise










In 1900, John D. Rockefeller controlled approximately 90 percent of all petroleum refining in the United States. He was, by some calculations, the richest private individual who had ever lived. He had a problem. Scientists were discovering that compounds derived from coal tar, a petroleum byproduct, could be used as synthetic medicines. Aspirin, derived from coal tar, had been launched by Bayer in 1899. The petroleum waste stream Rockefeller had previously had to dispose of could now be sold back to the public as medicine at a markup of roughly 10,000 percent. He had another problem. American medicine in 1900 was a competitive ecosystem of homeopaths, herbalists, naturopaths, osteopaths, midwives, and traditional doctors who used food, plants, water, and lifestyle as the primary tools of healing. Approximately half of all American medical schools taught some form of natural or alternative medicine. Rockefeller bought into the German pharmaceutical industry, eventually taking a substantial stake in IG Farben, the conglomerate that included Bayer, BASF, and Hoechst. He then commissioned a report. The report was written by Abraham Flexner, an educator with no medical training, funded by the Rockefeller and Carnegie Foundations, and published in 1910. It declared that natural and alternative medical schools were unscientific quackery. It recommended the closure of more than half of all American medical schools and the standardisation of the rest around medicine based on synthetic patented drugs. Congress acted. Half of American medical schools closed within a decade. The remainder accepted Rockefeller and Carnegie funding on the condition that their curricula be reorganised around pharmaceutical treatment. Nutrition was removed. Herbal medicine was removed. Lifestyle intervention was removed. The doctor's job was redefined: diagnose the symptom, prescribe the drug. The drugs were petroleum-derived. The petroleum was supplied by Rockefeller-controlled refineries. The medical schools were funded by Rockefeller. The journals were funded by Rockefeller. The AMA was supported by Rockefeller. The hospitals were funded by Rockefeller. By 1925, the American medical system was a vertically integrated extension of the petroleum industry, operating under the marketing slogan that it was scientific. This is the system that exists today. The pharmaceutical industry generates approximately $1.5 trillion in annual revenue. The American population, 4 percent of the global total, consumes approximately 50 percent of all pharmaceuticals manufactured. The system was not designed to make people healthy. The system was designed to manage symptoms in a way that produces lifetime customers. A healthy patient is a former customer. A managed patient, who takes the pill every day for the rest of their life, is an annuity. The objective has always been to keep you in that profitable corridor between healthy and dead. Long enough to keep buying. Not so well that you stop. The doctor who advises you to fix your metabolism by changing your diet is, from the point of view of the system that trained him, a defective product. The doctor who prescribes you a statin, a metformin, an antidepressant, and a blood pressure medication for life is performing exactly as designed. The system was designed by an oil baron who needed to sell the waste products of his refineries. It still functions, 116 years after the Flexner Report, exactly the way he designed it. You are the customer. The corridor is where you live.



What if the future of finance wasn’t just digital, but truly interoperable? Our latest trials show how Swift is helping make that a reality. We’ve completed pioneering digital asset interoperability trials with leading institutions, including BNP Paribas Securities Services, Intesa Sanpaolo and Societe Generale – FORGE, showcasing how Swift can orchestrate tokenised asset transactions across multiple platforms. This milestone builds on a broader set of recent trials, such as: ✅ ISO 20022 interoperability between blockchains with HSBC and Ant International ✅ Fiat and digital currency settlement with Citi ✅ Digital asset transaction exchange with Northern Trust and the Reserve Bank of Australia ✅ Bridging tokenised assets with UBS Asset Management and Chainlink Labs With these trials complete, we’re now adding a blockchain-based ledger to our infrastructure stack to enable real-time, 24/7 cross-border payments, in collaboration with more than 40 global banks. 👉 Read the full story: swift.com/news-events/ne… #DigitalAssets #Blockchain #Interoperability #SwiftLedger




The integration of #Ripple and Hidden Road continues to scale. The latest DTCC notice shows Hidden Road ($HRFI) officially going live on the NSCC directory March 2, 2026. Ripple Prime's role in bridging TradFi and DeFi will likely move post-trade volume to the XRPL










🚨 XRP’s Institutional Switch Is Here: Permissioned Dex Go Live Shortly Monica Long’s “2026 is the year of XRP with Institutional Scale Adoption” is here with Permissioned Dex and credentials. But What is a Permissioned DEX? A Permissioned DEX is a decentralized exchange where access is controlled, only verified participants can trade or provide liquidity. What that means in simple terms: • Normal DEX = anyone can trade. • Permissioned DEX = only approved, compliant participants can interact. 1️⃣ Why this exists: Institutions cannot trade on open systems with unknown counterparties due to compliance, AML, and regulatory requirements. 2️⃣ Why institutions need it: • They must know who they transact with • They must follow regulatory rules • They must prevent illicit activity exposure • They require audit trails and control 3️⃣ How it works: Verified entities (banks, payment providers, institutions) are granted access credentials and can trade within a controlled liquidity environment. 4️⃣ How institutions would use it: • Source compliant FX liquidity • Settle cross-border payments instantly • Swap tokenized assets securely • Provide regulated market making • Perform real-time settlement without counterparty risk 5️⃣ Why this matters for payments: Instead of waiting days for correspondent banking settlement, institutions can access compliant liquidity and settle transactions in seconds. 6️⃣ Why XRPL is suited for this: XRPL already supports built-in DEX functionality, fast settlement, low fees, and deterministic execution, permissioning adds the compliance layer institutions require. 7️⃣ Why this is huge: Permissioned liquidity unlocks institutional participation, the missing bridge between traditional finance and blockchain rails. 8️⃣ The Switch: When compliant institutions can finally access on-chain liquidity safely, XRPL stops being a crypto network… and starts functioning as financial infrastructure powered by XRP. Although, it will take time for institutions to actually deploy liquidity until CLARITY ACT and @DNAOnChain’s zk-credential system goes live, this is one of the biggest moment in XRPL’s history🌊


Every single time XRP starts pumping fast, a massive sell off (actually it's a wash trade) on Binance causes a collapse. First allowing shorts to liquidate, then once they are all gone, dump hard, and destroy all the longs, and cause a cataclysmic downturn. Now you'll see it come back up again. If this was real retail volume you would see an hourly 41M spike. I've been watching this for almost 3 years now. Same old story. No one to regulate, ful access to user data, @cz_binance companies have backdoor server access. #BoycottBinance it's the only way for them to learn.